Exhibit 99.1
Confidential
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001. Amended 01/01/11
Name of Entity: | Alterity Therapeutics Limited (ASX:ATH) |
ABN: | 37 080 699 065 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director: | Mr. Peter Marks |
Date of Last Notice: | 15 December 2022 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest | Direct and indirect | ||||
Nature of indirect interest Note: Provide details of the circumstances giving rise to the relevant interest. | Related entity | ||||
Date of change | 08 January 2024 | ||||
No. of securities held prior to change | |||||
Shares | Options | ||||
Direct | - | 7,000,000 | |||
Indirect | 43,111 | ||||
Total | 43,111 | 7,000,000 | |||
Class | Unlisted Options | ||||
Number acquired | |||||
Shares | Options | ||||
Direct | - | ||||
Indirect | 7,142,857 | 9,523,809 | |||
Total | 7,142,857 | 7,142,857 | |||
Number disposed | |||||
Shares | Options | ||||
Direct | - | - | |||
Indirect | - | - | |||
Total | - | - | |||
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | A$0.0035 per share with free attaching per Notice of EGM held 29 December 2023 |
+ See chapter 19 for defined terms. | |
01/01/2011 | Appendix 3Y Page 1 |
Confidential
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held after change | |||||
Shares | Options | ||||
Direct | - | 7,000,000 | |||
Indirect | 7,185,986 | 9,523,809 | |||
Total | 7,185,968 | 16,523,809 | |||
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Issue of shares and options under placement approved at the EGM held 29 December 2023 |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract | |
Nature of interest | |
Name of registered holder (if issued securities) | |
Date of change | |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
Interest acquired | |
Interest disposed | |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
Interest after change |
Part 3 - +Closed Period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided on what date was this provided? | N/A |
The CFO Solution |
+ See chapter 19 for defined terms. | |
Appendix 3Y Page 2 | 01/01/2011 |
Confidential
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.. Amended 01/01/11
Name of Entity: | Alterity Therapeutics Limited (ASX:ATH) |
ABN: | 37 080 699 065 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director: | Mr. Brian Meltzer |
Date of Last Notice: | 15 December 2022 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest | Direct | ||||
Nature of indirect interest Note: Provide details of the circumstances giving rise to the relevant interest. | Related entity | ||||
Date of change | 08 January 2024 | ||||
No. of securities held prior to change | |||||
Shares | Options | ||||
Direct | - | 7,000,000 | |||
Indirect | 326,666 | - | |||
Total | 326,666 | 8,250,000 | |||
Class | Unlisted Options | ||||
Number acquired | |||||
Shares | Options | ||||
Direct | 7,142,857 | 9,523,809 | |||
Indirect | - | - | |||
Total | - | - | |||
Number disposed | |||||
Shares | Options | ||||
Direct | - | - | |||
Indirect | - | - | |||
Total | - | - |
+ See chapter 19 for defined terms. | |
11/3/2002 | Appendix 3Y Page 1 |
Confidential
Appendix 3Y
Change of Director’s Interest Notice
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | A$0.0035 per share with free attaching per Notice of EGM held 29 December 2023 | ||||
No. of securities held after change | |||||
Shares | Options | ||||
Direct | 7,142,857 | 16,523,809 | |||
Indirect | 326,666 | - | |||
Total | 7,469,523 | 16,523,809 | |||
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Issue of shares and options under placement approved at the EGM held 29 December 2023 |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | |
Name of registered holder (if issued securities) | |
Date of change | |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
Interest acquired | |
Interest disposed | |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
Interest after change |
Part 3 - +Closed Period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided on what date was this provided? | N/A |
The CFO Solution |
+ See chapter 19 for defined terms. | |
Appendix 3Y Page 2 | 01/01/2011 |